カテゴリー： 世界, 医療/バイオ, LP Information

世界の経口ワクチン投与市場予測 2023年-2029年

【英語タイトル】Global Oral Vaccine Delivery Market Growth 2023-2029

LP Informationが出版した調査資料（LP23DC01801）・商品コード：LP23DC01801
・発行会社（調査会社）：LP Information
・発行日：2023年11月
・ページ数：110
・レポート言語：英語
・レポート形式：PDF
・納品方法：Eメール（受注後2-3営業日）
・調査対象地域：グローバル、日本、アメリカ、ヨーロッパ、アジア、中国など
・産業分野：医薬品＆医療
◆販売価格オプション（消費税別）
Single User（1名様閲覧用）USD3,660 ⇒換算￥549,000見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）USD5,490 ⇒換算￥823,500見積依頼/購入/質問フォーム
Corporate User（閲覧人数制限なし）USD7,320 ⇒換算￥1,098,000見積依頼/購入/質問フォーム
※販売価格オプションの説明
※お支払金額：換算金額（日本円）＋消費税
※納期：即日〜2営業日（3日以上かかる場合は別途表記又はご連絡）
※お支払方法：納品日＋5日以内に請求書を発行・送付（請求書発行日より2ヶ月以内に銀行振込、振込先：三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能）
❖ レポートの概要 ❖

LPインフォメーションの最新刊調査レポート「世界の経口ワクチン投与市場」は、過去の販売実績から2022年の世界の経口ワクチン投与の総販売量を検討し、2023年から2029年の予測される経口ワクチン投与の販売量を地域別・市場分野別に包括的に分析しています。本調査レポートでは、地域別、市場分野別、サブセクター別の経口ワクチン投与の市場規模を掲載し、XXX百万米ドル規模の世界の経口ワクチン投与市場の詳細な分析を提供します。本インサイトレポートは、世界の経口ワクチン投与業界を包括的に分析し、製品セグメント、企業情報、売上、市場シェア、最新動向、M&A活動に関する主要トレンドを明らかにしています。
また、本レポートでは、加速する世界の経口ワクチン投与市場における各社の独自のポジションをより深く理解するために、経口ワクチン投与製品ポートフォリオ、能力、市場参入戦略、市場でのポジション、海外展開に焦点を当て、主要なグローバル企業の戦略を分析しています。

世界の経口ワクチン投与市場規模は、2022年のXXX百万米ドルから2029年にはXXX百万米ドルに成長すると予測され、2023年から2029年までの年平均成長率は000%と予測されます。経口ワクチン投与の米国市場は、2022年のXXX百万米ドルから2029年にはXXX百万米ドルに増加し、2023年から2029年までのCAGRは000％と予測されています。経口ワクチン投与の中国市場は、2023年から2029年までの年平均000％成長率で、2022年のXXX百万米ドルから2029年にはXXX百万米ドルに増加すると推定されます。経口ワクチン投与のヨーロッパ市場は、2023年から2029年にかけて年平均000％成長率で、2022年のXXX百万米ドルから2029年にはXXX百万米ドルに増加すると推定されています。

経口ワクチン投与の世界主要メーカーとしては、Merck、 GSK、 Sanofi、 Lanzhou Institute、 Serum Institute、 Valneva、 Shanghai United Cell、 Bibcol、 PaxVax、 Vabiotech、 Tiantan Biological、 EuBiologics、 Panacea Biotec Ltd、 Bio-Med、 Halfkin Bio-Pharmaceuticalsなどを掲載しており、売上の面では、世界の2大企業が2022年にほぼ000％のシェアを占めています。

本レポートでは、製品タイプ、用途、主要メーカー、主要地域、国別の経口ワクチン投与市場の包括的な概要、市場シェア、成長機会などの情報を提供しています。

【市場細分化】

この調査では経口ワクチン投与市場をセグメンテーションし、種類別 (ロタウイルスワクチン、コレラワクチン、経口ポリオワクチン、その他)、用途別 (公的関与、民間)、および地域別 (アジア太平洋、南北アメリカ、ヨーロッパ、および中東・アフリカ) の市場規模を予測しています。

・種類別区分：ロタウイルスワクチン、コレラワクチン、経口ポリオワクチン、その他

・用途別区分：公的関与、民間

・地域別区分
南北アメリカ（アメリカ、カナダ、メキシコ、ブラジル）
アジア太平洋（中国、日本、韓国、東南アジア、インド、オーストラリア）
ヨーロッパ（ドイツ、フランス、イギリス、イタリア、ロシア）
中東・アフリカ（エジプト、南アフリカ、イスラエル、トルコ、GCC諸国）

【本レポートで扱う主な質問】

・世界の経口ワクチン投与市場の10年間の市場状況・展望は？
・世界および地域別に見た経口ワクチン投与市場成長の要因は何か？
・経口ワクチン投与の市場機会はエンドマーケットの規模によってどのように変化するのか？
・経口ワクチン投与のタイプ別、用途別の内訳は？
・新型コロナウイルス感染症とロシア・ウクライナ戦争の影響は？

********* 目次 *********

レポートの範囲
・市場の紹介
・分析対象期間
・調査の目的
・調査手法
・調査プロセスおよびデータソース
・経済指標
・通貨

エグゼクティブサマリー
・世界市場の概要：経口ワクチン投与の年間販売量2018-2029、地域別現状・将来分析
・経口ワクチン投与の種類別セグメント：ロタウイルスワクチン、コレラワクチン、経口ポリオワクチン、その他
・経口ワクチン投与の種類別販売量：2018-2023年の販売量、売上、市場シェア、販売価格
・経口ワクチン投与の用途別セグメント：公的関与、民間
・経口ワクチン投与の用途別販売量：2018-2023年の販売量、売上、市場シェア、販売価格

企業別世界の経口ワクチン投与市場
・企業別のグローバル経口ワクチン投与市場データ：2018-2023年の年間販売量、市場シェア
・企業別の経口ワクチン投与の年間売上：2018-2023年の売上、市場シェア
・企業別の経口ワクチン投与販売価格
・主要企業の経口ワクチン投与生産地域、販売地域、製品タイプ
・市場集中度分析
・新製品および潜在的な参加者
・合併と買収、拡大

経口ワクチン投与の地域別レビュー
・地域別の経口ワクチン投与市場規模2018-2023：年間販売量、売上
・主要国別の経口ワクチン投与市場規模2018-2023：年間販売量、売上
・南北アメリカの経口ワクチン投与販売の成長
・アジア太平洋の経口ワクチン投与販売の成長
・ヨーロッパの経口ワクチン投与販売の成長
・中東・アフリカの経口ワクチン投与販売の成長

南北アメリカ市場
・南北アメリカの国別の経口ワクチン投与販売量、売上（2018-2023）
・南北アメリカの経口ワクチン投与の種類別販売量
・南北アメリカの経口ワクチン投与の用途別販売量
・アメリカ市場
・カナダ市場
・メキシコ市場
・ブラジル市場

アジア太平洋市場
・アジア太平洋の国別の経口ワクチン投与販売量、売上（2018-2023）
・アジア太平洋の経口ワクチン投与の種類別販売量
・アジア太平洋の経口ワクチン投与の用途別販売量
・中国市場
・日本市場
・韓国市場
・東南アジア市場
・インド市場
・オーストラリア市場
・台湾市場

ヨーロッパ市場
・ヨーロッパの国別の経口ワクチン投与販売量、売上（2018-2023）
・ヨーロッパの経口ワクチン投与の種類別販売量
・ヨーロッパの経口ワクチン投与の用途別販売量
・ドイツ市場
・フランス市場
・イギリス市場
・イタリア市場
・ロシア市場

中東・アフリカ市場
・中東・アフリカの国別の経口ワクチン投与販売量、売上（2018-2023）
・中東・アフリカの経口ワクチン投与の種類別販売量
・中東・アフリカの経口ワクチン投与の用途別販売量
・エジプト市場
・南アフリカ市場
・イスラエル市場
・トルコ市場
・GCC諸国市場

市場の成長要因、課題、動向
・市場の成長要因および成長機会分析
・市場の課題およびリスク
・市場動向

製造コスト構造分析
・原材料とサプライヤー
・経口ワクチン投与の製造コスト構造分析
・経口ワクチン投与の製造プロセス分析
・経口ワクチン投与の産業チェーン構造

マーケティング、販売業者および顧客
・販売チャンネル：直接販売チャンネル、間接販売チャンネル
・経口ワクチン投与の主要なグローバル販売業者
・経口ワクチン投与の主要なグローバル顧客

地域別の経口ワクチン投与市場予測レビュー
・地域別の経口ワクチン投与市場規模予測（2024-2029）
・南北アメリカの国別予測
・アジア太平洋の国別予測
・ヨーロッパの国別予測
・経口ワクチン投与の種類別市場規模予測
・経口ワクチン投与の用途別市場規模予測

主要企業分析
Merck、 GSK、 Sanofi、 Lanzhou Institute、 Serum Institute、 Valneva、 Shanghai United Cell、 Bibcol、 PaxVax、 Vabiotech、 Tiantan Biological、 EuBiologics、 Panacea Biotec Ltd、 Bio-Med、 Halfkin Bio-Pharmaceuticals
・企業情報
・経口ワクチン投与製品
・経口ワクチン投与販売量、売上、価格、粗利益（2018-2023）
・主要ビジネス概要
・最新動向

調査結果および結論

The global Oral Vaccine Delivery market size is projected to grow from US$ 2455.4 million in 2022 to US$ 3571.4 million in 2029; it is expected to grow at a CAGR of 5.5% from 2023 to 2029.
United States market for Oral Vaccine Delivery is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Oral Vaccine Delivery is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Oral Vaccine Delivery is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Oral Vaccine Delivery players cover Merck, GSK, Sanofi, Lanzhou Institute, Serum Institute, Valneva, Shanghai United Cell, Bibcol and PaxVax, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
Oral vaccines have several attractive features compared with parenteral vaccines, but studies on their use have been limited almost exclusively to protection against mucosally transmitted pathogens.
LPI (LP Information)’ newest research report, the “Oral Vaccine Delivery Industry Forecast” looks at past sales and reviews total world Oral Vaccine Delivery sales in 2022, providing a comprehensive analysis by region and market sector of projected Oral Vaccine Delivery sales for 2023 through 2029. With Oral Vaccine Delivery sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Oral Vaccine Delivery industry.
This Insight Report provides a comprehensive analysis of the global Oral Vaccine Delivery landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Oral Vaccine Delivery portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Oral Vaccine Delivery market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Oral Vaccine Delivery and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Oral Vaccine Delivery.
This report presents a comprehensive overview, market shares, and growth opportunities of Oral Vaccine Delivery market by product type, application, key manufacturers and key regions and countries.
Market Segmentation:
Segmentation by type
Rotavirus Vaccine
Cholera Vaccine
Oral Polio Vaccine
Other
Segmentation by application
Public
Private
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company’s coverage, product portfolio, its market penetration.
Merck
GSK
Sanofi
Lanzhou Institute
Serum Institute
Valneva
Shanghai United Cell
Bibcol
PaxVax
Vabiotech
Tiantan Biological
EuBiologics
Panacea Biotec Ltd
Bio-Med
Halfkin Bio-Pharmaceuticals
Key Questions Addressed in this Report
What is the 10-year outlook for the global Oral Vaccine Delivery market?
What factors are driving Oral Vaccine Delivery market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Oral Vaccine Delivery market opportunities vary by end market size?
How does Oral Vaccine Delivery break out type, application?
What are the influences of COVID-19 and Russia-Ukraine war?

❖ レポートの目次 ❖

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Oral Vaccine Delivery Annual Sales 2018-2029
2.1.2 World Current & Future Analysis for Oral Vaccine Delivery by Geographic Region, 2018, 2022 & 2029
2.1.3 World Current & Future Analysis for Oral Vaccine Delivery by Country/Region, 2018, 2022 & 2029
2.2 Oral Vaccine Delivery Segment by Type
2.2.1 Rotavirus Vaccine
2.2.2 Cholera Vaccine
2.2.3 Oral Polio Vaccine
2.2.4 Other
2.3 Oral Vaccine Delivery Sales by Type
2.3.1 Global Oral Vaccine Delivery Sales Market Share by Type (2018-2023)
2.3.2 Global Oral Vaccine Delivery Revenue and Market Share by Type (2018-2023)
2.3.3 Global Oral Vaccine Delivery Sale Price by Type (2018-2023)
2.4 Oral Vaccine Delivery Segment by Application
2.4.1 Public
2.4.2 Private
2.5 Oral Vaccine Delivery Sales by Application
2.5.1 Global Oral Vaccine Delivery Sale Market Share by Application (2018-2023)
2.5.2 Global Oral Vaccine Delivery Revenue and Market Share by Application (2018-2023)
2.5.3 Global Oral Vaccine Delivery Sale Price by Application (2018-2023)
3 Global Oral Vaccine Delivery by Company
3.1 Global Oral Vaccine Delivery Breakdown Data by Company
3.1.1 Global Oral Vaccine Delivery Annual Sales by Company (2018-2023)
3.1.2 Global Oral Vaccine Delivery Sales Market Share by Company (2018-2023)
3.2 Global Oral Vaccine Delivery Annual Revenue by Company (2018-2023)
3.2.1 Global Oral Vaccine Delivery Revenue by Company (2018-2023)
3.2.2 Global Oral Vaccine Delivery Revenue Market Share by Company (2018-2023)
3.3 Global Oral Vaccine Delivery Sale Price by Company
3.4 Key Manufacturers Oral Vaccine Delivery Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Oral Vaccine Delivery Product Location Distribution
3.4.2 Players Oral Vaccine Delivery Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Oral Vaccine Delivery by Geographic Region
4.1 World Historic Oral Vaccine Delivery Market Size by Geographic Region (2018-2023)
4.1.1 Global Oral Vaccine Delivery Annual Sales by Geographic Region (2018-2023)
4.1.2 Global Oral Vaccine Delivery Annual Revenue by Geographic Region (2018-2023)
4.2 World Historic Oral Vaccine Delivery Market Size by Country/Region (2018-2023)
4.2.1 Global Oral Vaccine Delivery Annual Sales by Country/Region (2018-2023)
4.2.2 Global Oral Vaccine Delivery Annual Revenue by Country/Region (2018-2023)
4.3 Americas Oral Vaccine Delivery Sales Growth
4.4 APAC Oral Vaccine Delivery Sales Growth
4.5 Europe Oral Vaccine Delivery Sales Growth
4.6 Middle East & Africa Oral Vaccine Delivery Sales Growth
5 Americas
5.1 Americas Oral Vaccine Delivery Sales by Country
5.1.1 Americas Oral Vaccine Delivery Sales by Country (2018-2023)
5.1.2 Americas Oral Vaccine Delivery Revenue by Country (2018-2023)
5.2 Americas Oral Vaccine Delivery Sales by Type
5.3 Americas Oral Vaccine Delivery Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Oral Vaccine Delivery Sales by Region
6.1.1 APAC Oral Vaccine Delivery Sales by Region (2018-2023)
6.1.2 APAC Oral Vaccine Delivery Revenue by Region (2018-2023)
6.2 APAC Oral Vaccine Delivery Sales by Type
6.3 APAC Oral Vaccine Delivery Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Oral Vaccine Delivery by Country
7.1.1 Europe Oral Vaccine Delivery Sales by Country (2018-2023)
7.1.2 Europe Oral Vaccine Delivery Revenue by Country (2018-2023)
7.2 Europe Oral Vaccine Delivery Sales by Type
7.3 Europe Oral Vaccine Delivery Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Oral Vaccine Delivery by Country
8.1.1 Middle East & Africa Oral Vaccine Delivery Sales by Country (2018-2023)
8.1.2 Middle East & Africa Oral Vaccine Delivery Revenue by Country (2018-2023)
8.2 Middle East & Africa Oral Vaccine Delivery Sales by Type
8.3 Middle East & Africa Oral Vaccine Delivery Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Oral Vaccine Delivery
10.3 Manufacturing Process Analysis of Oral Vaccine Delivery
10.4 Industry Chain Structure of Oral Vaccine Delivery
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Oral Vaccine Delivery Distributors
11.3 Oral Vaccine Delivery Customer
12 World Forecast Review for Oral Vaccine Delivery by Geographic Region
12.1 Global Oral Vaccine Delivery Market Size Forecast by Region
12.1.1 Global Oral Vaccine Delivery Forecast by Region (2024-2029)
12.1.2 Global Oral Vaccine Delivery Annual Revenue Forecast by Region (2024-2029)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Oral Vaccine Delivery Forecast by Type
12.7 Global Oral Vaccine Delivery Forecast by Application
13 Key Players Analysis
13.1 Merck
13.1.1 Merck Company Information
13.1.2 Merck Oral Vaccine Delivery Product Portfolios and Specifications
13.1.3 Merck Oral Vaccine Delivery Sales, Revenue, Price and Gross Margin (2018-2023)
13.1.4 Merck Main Business Overview
13.1.5 Merck Latest Developments
13.2 GSK
13.2.1 GSK Company Information
13.2.2 GSK Oral Vaccine Delivery Product Portfolios and Specifications
13.2.3 GSK Oral Vaccine Delivery Sales, Revenue, Price and Gross Margin (2018-2023)
13.2.4 GSK Main Business Overview
13.2.5 GSK Latest Developments
13.3 Sanofi
13.3.1 Sanofi Company Information
13.3.2 Sanofi Oral Vaccine Delivery Product Portfolios and Specifications
13.3.3 Sanofi Oral Vaccine Delivery Sales, Revenue, Price and Gross Margin (2018-2023)
13.3.4 Sanofi Main Business Overview
13.3.5 Sanofi Latest Developments
13.4 Lanzhou Institute
13.4.1 Lanzhou Institute Company Information
13.4.2 Lanzhou Institute Oral Vaccine Delivery Product Portfolios and Specifications
13.4.3 Lanzhou Institute Oral Vaccine Delivery Sales, Revenue, Price and Gross Margin (2018-2023)
13.4.4 Lanzhou Institute Main Business Overview
13.4.5 Lanzhou Institute Latest Developments
13.5 Serum Institute
13.5.1 Serum Institute Company Information
13.5.2 Serum Institute Oral Vaccine Delivery Product Portfolios and Specifications
13.5.3 Serum Institute Oral Vaccine Delivery Sales, Revenue, Price and Gross Margin (2018-2023)
13.5.4 Serum Institute Main Business Overview
13.5.5 Serum Institute Latest Developments
13.6 Valneva
13.6.1 Valneva Company Information
13.6.2 Valneva Oral Vaccine Delivery Product Portfolios and Specifications
13.6.3 Valneva Oral Vaccine Delivery Sales, Revenue, Price and Gross Margin (2018-2023)
13.6.4 Valneva Main Business Overview
13.6.5 Valneva Latest Developments
13.7 Shanghai United Cell
13.7.1 Shanghai United Cell Company Information
13.7.2 Shanghai United Cell Oral Vaccine Delivery Product Portfolios and Specifications
13.7.3 Shanghai United Cell Oral Vaccine Delivery Sales, Revenue, Price and Gross Margin (2018-2023)
13.7.4 Shanghai United Cell Main Business Overview
13.7.5 Shanghai United Cell Latest Developments
13.8 Bibcol
13.8.1 Bibcol Company Information
13.8.2 Bibcol Oral Vaccine Delivery Product Portfolios and Specifications
13.8.3 Bibcol Oral Vaccine Delivery Sales, Revenue, Price and Gross Margin (2018-2023)
13.8.4 Bibcol Main Business Overview
13.8.5 Bibcol Latest Developments
13.9 PaxVax
13.9.1 PaxVax Company Information
13.9.2 PaxVax Oral Vaccine Delivery Product Portfolios and Specifications
13.9.3 PaxVax Oral Vaccine Delivery Sales, Revenue, Price and Gross Margin (2018-2023)
13.9.4 PaxVax Main Business Overview
13.9.5 PaxVax Latest Developments
13.10 Vabiotech
13.10.1 Vabiotech Company Information
13.10.2 Vabiotech Oral Vaccine Delivery Product Portfolios and Specifications
13.10.3 Vabiotech Oral Vaccine Delivery Sales, Revenue, Price and Gross Margin (2018-2023)
13.10.4 Vabiotech Main Business Overview
13.10.5 Vabiotech Latest Developments
13.11 Tiantan Biological
13.11.1 Tiantan Biological Company Information
13.11.2 Tiantan Biological Oral Vaccine Delivery Product Portfolios and Specifications
13.11.3 Tiantan Biological Oral Vaccine Delivery Sales, Revenue, Price and Gross Margin (2018-2023)
13.11.4 Tiantan Biological Main Business Overview
13.11.5 Tiantan Biological Latest Developments
13.12 EuBiologics
13.12.1 EuBiologics Company Information
13.12.2 EuBiologics Oral Vaccine Delivery Product Portfolios and Specifications
13.12.3 EuBiologics Oral Vaccine Delivery Sales, Revenue, Price and Gross Margin (2018-2023)
13.12.4 EuBiologics Main Business Overview
13.12.5 EuBiologics Latest Developments
13.13 Panacea Biotec Ltd
13.13.1 Panacea Biotec Ltd Company Information
13.13.2 Panacea Biotec Ltd Oral Vaccine Delivery Product Portfolios and Specifications
13.13.3 Panacea Biotec Ltd Oral Vaccine Delivery Sales, Revenue, Price and Gross Margin (2018-2023)
13.13.4 Panacea Biotec Ltd Main Business Overview
13.13.5 Panacea Biotec Ltd Latest Developments
13.14 Bio-Med
13.14.1 Bio-Med Company Information
13.14.2 Bio-Med Oral Vaccine Delivery Product Portfolios and Specifications
13.14.3 Bio-Med Oral Vaccine Delivery Sales, Revenue, Price and Gross Margin (2018-2023)
13.14.4 Bio-Med Main Business Overview
13.14.5 Bio-Med Latest Developments
13.15 Halfkin Bio-Pharmaceuticals
13.15.1 Halfkin Bio-Pharmaceuticals Company Information
13.15.2 Halfkin Bio-Pharmaceuticals Oral Vaccine Delivery Product Portfolios and Specifications
13.15.3 Halfkin Bio-Pharmaceuticals Oral Vaccine Delivery Sales, Revenue, Price and Gross Margin (2018-2023)
13.15.4 Halfkin Bio-Pharmaceuticals Main Business Overview
13.15.5 Halfkin Bio-Pharmaceuticals Latest Developments
14 Research Findings and Conclusion

List of Tables
Table 1. Oral Vaccine Delivery Annual Sales CAGR by Geographic Region (2018, 2022 & 2029) & ($ millions)
Table 2. Oral Vaccine Delivery Annual Sales CAGR by Country/Region (2018, 2022 & 2029) & ($ millions)
Table 3. Major Players of Rotavirus Vaccine
Table 4. Major Players of Cholera Vaccine
Table 5. Major Players of Oral Polio Vaccine
Table 6. Major Players of Other
Table 7. Global Oral Vaccine Delivery Sales by Type (2018-2023) & (K Units)
Table 8. Global Oral Vaccine Delivery Sales Market Share by Type (2018-2023)
Table 9. Global Oral Vaccine Delivery Revenue by Type (2018-2023) & ($ million)
Table 10. Global Oral Vaccine Delivery Revenue Market Share by Type (2018-2023)
Table 11. Global Oral Vaccine Delivery Sale Price by Type (2018-2023) & (US$/Unit)
Table 12. Global Oral Vaccine Delivery Sales by Application (2018-2023) & (K Units)
Table 13. Global Oral Vaccine Delivery Sales Market Share by Application (2018-2023)
Table 14. Global Oral Vaccine Delivery Revenue by Application (2018-2023)
Table 15. Global Oral Vaccine Delivery Revenue Market Share by Application (2018-2023)
Table 16. Global Oral Vaccine Delivery Sale Price by Application (2018-2023) & (US$/Unit)
Table 17. Global Oral Vaccine Delivery Sales by Company (2018-2023) & (K Units)
Table 18. Global Oral Vaccine Delivery Sales Market Share by Company (2018-2023)
Table 19. Global Oral Vaccine Delivery Revenue by Company (2018-2023) ($ Millions)
Table 20. Global Oral Vaccine Delivery Revenue Market Share by Company (2018-2023)
Table 21. Global Oral Vaccine Delivery Sale Price by Company (2018-2023) & (US$/Unit)
Table 22. Key Manufacturers Oral Vaccine Delivery Producing Area Distribution and Sales Area
Table 23. Players Oral Vaccine Delivery Products Offered
Table 24. Oral Vaccine Delivery Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
Table 25. New Products and Potential Entrants
Table 26. Mergers & Acquisitions, Expansion
Table 27. Global Oral Vaccine Delivery Sales by Geographic Region (2018-2023) & (K Units)
Table 28. Global Oral Vaccine Delivery Sales Market Share Geographic Region (2018-2023)
Table 29. Global Oral Vaccine Delivery Revenue by Geographic Region (2018-2023) & ($ millions)
Table 30. Global Oral Vaccine Delivery Revenue Market Share by Geographic Region (2018-2023)
Table 31. Global Oral Vaccine Delivery Sales by Country/Region (2018-2023) & (K Units)
Table 32. Global Oral Vaccine Delivery Sales Market Share by Country/Region (2018-2023)
Table 33. Global Oral Vaccine Delivery Revenue by Country/Region (2018-2023) & ($ millions)
Table 34. Global Oral Vaccine Delivery Revenue Market Share by Country/Region (2018-2023)
Table 35. Americas Oral Vaccine Delivery Sales by Country (2018-2023) & (K Units)
Table 36. Americas Oral Vaccine Delivery Sales Market Share by Country (2018-2023)
Table 37. Americas Oral Vaccine Delivery Revenue by Country (2018-2023) & ($ Millions)
Table 38. Americas Oral Vaccine Delivery Revenue Market Share by Country (2018-2023)
Table 39. Americas Oral Vaccine Delivery Sales by Type (2018-2023) & (K Units)
Table 40. Americas Oral Vaccine Delivery Sales by Application (2018-2023) & (K Units)
Table 41. APAC Oral Vaccine Delivery Sales by Region (2018-2023) & (K Units)
Table 42. APAC Oral Vaccine Delivery Sales Market Share by Region (2018-2023)
Table 43. APAC Oral Vaccine Delivery Revenue by Region (2018-2023) & ($ Millions)
Table 44. APAC Oral Vaccine Delivery Revenue Market Share by Region (2018-2023)
Table 45. APAC Oral Vaccine Delivery Sales by Type (2018-2023) & (K Units)
Table 46. APAC Oral Vaccine Delivery Sales by Application (2018-2023) & (K Units)
Table 47. Europe Oral Vaccine Delivery Sales by Country (2018-2023) & (K Units)
Table 48. Europe Oral Vaccine Delivery Sales Market Share by Country (2018-2023)
Table 49. Europe Oral Vaccine Delivery Revenue by Country (2018-2023) & ($ Millions)
Table 50. Europe Oral Vaccine Delivery Revenue Market Share by Country (2018-2023)
Table 51. Europe Oral Vaccine Delivery Sales by Type (2018-2023) & (K Units)
Table 52. Europe Oral Vaccine Delivery Sales by Application (2018-2023) & (K Units)
Table 53. Middle East & Africa Oral Vaccine Delivery Sales by Country (2018-2023) & (K Units)
Table 54. Middle East & Africa Oral Vaccine Delivery Sales Market Share by Country (2018-2023)
Table 55. Middle East & Africa Oral Vaccine Delivery Revenue by Country (2018-2023) & ($ Millions)
Table 56. Middle East & Africa Oral Vaccine Delivery Revenue Market Share by Country (2018-2023)
Table 57. Middle East & Africa Oral Vaccine Delivery Sales by Type (2018-2023) & (K Units)
Table 58. Middle East & Africa Oral Vaccine Delivery Sales by Application (2018-2023) & (K Units)
Table 59. Key Market Drivers & Growth Opportunities of Oral Vaccine Delivery
Table 60. Key Market Challenges & Risks of Oral Vaccine Delivery
Table 61. Key Industry Trends of Oral Vaccine Delivery
Table 62. Oral Vaccine Delivery Raw Material
Table 63. Key Suppliers of Raw Materials
Table 64. Oral Vaccine Delivery Distributors List
Table 65. Oral Vaccine Delivery Customer List
Table 66. Global Oral Vaccine Delivery Sales Forecast by Region (2024-2029) & (K Units)
Table 67. Global Oral Vaccine Delivery Revenue Forecast by Region (2024-2029) & ($ millions)
Table 68. Americas Oral Vaccine Delivery Sales Forecast by Country (2024-2029) & (K Units)
Table 69. Americas Oral Vaccine Delivery Revenue Forecast by Country (2024-2029) & ($ millions)
Table 70. APAC Oral Vaccine Delivery Sales Forecast by Region (2024-2029) & (K Units)
Table 71. APAC Oral Vaccine Delivery Revenue Forecast by Region (2024-2029) & ($ millions)
Table 72. Europe Oral Vaccine Delivery Sales Forecast by Country (2024-2029) & (K Units)
Table 73. Europe Oral Vaccine Delivery Revenue Forecast by Country (2024-2029) & ($ millions)
Table 74. Middle East & Africa Oral Vaccine Delivery Sales Forecast by Country (2024-2029) & (K Units)
Table 75. Middle East & Africa Oral Vaccine Delivery Revenue Forecast by Country (2024-2029) & ($ millions)
Table 76. Global Oral Vaccine Delivery Sales Forecast by Type (2024-2029) & (K Units)
Table 77. Global Oral Vaccine Delivery Revenue Forecast by Type (2024-2029) & ($ Millions)
Table 78. Global Oral Vaccine Delivery Sales Forecast by Application (2024-2029) & (K Units)
Table 79. Global Oral Vaccine Delivery Revenue Forecast by Application (2024-2029) & ($ Millions)
Table 80. Merck Basic Information, Oral Vaccine Delivery Manufacturing Base, Sales Area and Its Competitors
Table 81. Merck Oral Vaccine Delivery Product Portfolios and Specifications
Table 82. Merck Oral Vaccine Delivery Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 83. Merck Main Business
Table 84. Merck Latest Developments
Table 85. GSK Basic Information, Oral Vaccine Delivery Manufacturing Base, Sales Area and Its Competitors
Table 86. GSK Oral Vaccine Delivery Product Portfolios and Specifications
Table 87. GSK Oral Vaccine Delivery Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 88. GSK Main Business
Table 89. GSK Latest Developments
Table 90. Sanofi Basic Information, Oral Vaccine Delivery Manufacturing Base, Sales Area and Its Competitors
Table 91. Sanofi Oral Vaccine Delivery Product Portfolios and Specifications
Table 92. Sanofi Oral Vaccine Delivery Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 93. Sanofi Main Business
Table 94. Sanofi Latest Developments
Table 95. Lanzhou Institute Basic Information, Oral Vaccine Delivery Manufacturing Base, Sales Area and Its Competitors
Table 96. Lanzhou Institute Oral Vaccine Delivery Product Portfolios and Specifications
Table 97. Lanzhou Institute Oral Vaccine Delivery Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 98. Lanzhou Institute Main Business
Table 99. Lanzhou Institute Latest Developments
Table 100. Serum Institute Basic Information, Oral Vaccine Delivery Manufacturing Base, Sales Area and Its Competitors
Table 101. Serum Institute Oral Vaccine Delivery Product Portfolios and Specifications
Table 102. Serum Institute Oral Vaccine Delivery Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 103. Serum Institute Main Business
Table 104. Serum Institute Latest Developments
Table 105. Valneva Basic Information, Oral Vaccine Delivery Manufacturing Base, Sales Area and Its Competitors
Table 106. Valneva Oral Vaccine Delivery Product Portfolios and Specifications
Table 107. Valneva Oral Vaccine Delivery Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 108. Valneva Main Business
Table 109. Valneva Latest Developments
Table 110. Shanghai United Cell Basic Information, Oral Vaccine Delivery Manufacturing Base, Sales Area and Its Competitors
Table 111. Shanghai United Cell Oral Vaccine Delivery Product Portfolios and Specifications
Table 112. Shanghai United Cell Oral Vaccine Delivery Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 113. Shanghai United Cell Main Business
Table 114. Shanghai United Cell Latest Developments
Table 115. Bibcol Basic Information, Oral Vaccine Delivery Manufacturing Base, Sales Area and Its Competitors
Table 116. Bibcol Oral Vaccine Delivery Product Portfolios and Specifications
Table 117. Bibcol Oral Vaccine Delivery Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 118. Bibcol Main Business
Table 119. Bibcol Latest Developments
Table 120. PaxVax Basic Information, Oral Vaccine Delivery Manufacturing Base, Sales Area and Its Competitors
Table 121. PaxVax Oral Vaccine Delivery Product Portfolios and Specifications
Table 122. PaxVax Oral Vaccine Delivery Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 123. PaxVax Main Business
Table 124. PaxVax Latest Developments
Table 125. Vabiotech Basic Information, Oral Vaccine Delivery Manufacturing Base, Sales Area and Its Competitors
Table 126. Vabiotech Oral Vaccine Delivery Product Portfolios and Specifications
Table 127. Vabiotech Oral Vaccine Delivery Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 128. Vabiotech Main Business
Table 129. Vabiotech Latest Developments
Table 130. Tiantan Biological Basic Information, Oral Vaccine Delivery Manufacturing Base, Sales Area and Its Competitors
Table 131. Tiantan Biological Oral Vaccine Delivery Product Portfolios and Specifications
Table 132. Tiantan Biological Oral Vaccine Delivery Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 133. Tiantan Biological Main Business
Table 134. Tiantan Biological Latest Developments
Table 135. EuBiologics Basic Information, Oral Vaccine Delivery Manufacturing Base, Sales Area and Its Competitors
Table 136. EuBiologics Oral Vaccine Delivery Product Portfolios and Specifications
Table 137. EuBiologics Oral Vaccine Delivery Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 138. EuBiologics Main Business
Table 139. EuBiologics Latest Developments
Table 140. Panacea Biotec Ltd Basic Information, Oral Vaccine Delivery Manufacturing Base, Sales Area and Its Competitors
Table 141. Panacea Biotec Ltd Oral Vaccine Delivery Product Portfolios and Specifications
Table 142. Panacea Biotec Ltd Oral Vaccine Delivery Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 143. Panacea Biotec Ltd Main Business
Table 144. Panacea Biotec Ltd Latest Developments
Table 145. Bio-Med Basic Information, Oral Vaccine Delivery Manufacturing Base, Sales Area and Its Competitors
Table 146. Bio-Med Oral Vaccine Delivery Product Portfolios and Specifications
Table 147. Bio-Med Oral Vaccine Delivery Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 148. Bio-Med Main Business
Table 149. Bio-Med Latest Developments
Table 150. Halfkin Bio-Pharmaceuticals Basic Information, Oral Vaccine Delivery Manufacturing Base, Sales Area and Its Competitors
Table 151. Halfkin Bio-Pharmaceuticals Oral Vaccine Delivery Product Portfolios and Specifications
Table 152. Halfkin Bio-Pharmaceuticals Oral Vaccine Delivery Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 153. Halfkin Bio-Pharmaceuticals Main Business
Table 154. Halfkin Bio-Pharmaceuticals Latest Developments
List of Figures
Figure 1. Picture of Oral Vaccine Delivery
Figure 2. Oral Vaccine Delivery Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Oral Vaccine Delivery Sales Growth Rate 2018-2029 (K Units)
Figure 7. Global Oral Vaccine Delivery Revenue Growth Rate 2018-2029 ($ Millions)
Figure 8. Oral Vaccine Delivery Sales by Region (2018, 2022 & 2029) & ($ Millions)
Figure 9. Product Picture of Rotavirus Vaccine
Figure 10. Product Picture of Cholera Vaccine
Figure 11. Product Picture of Oral Polio Vaccine
Figure 12. Product Picture of Other
Figure 13. Global Oral Vaccine Delivery Sales Market Share by Type in 2022
Figure 14. Global Oral Vaccine Delivery Revenue Market Share by Type (2018-2023)
Figure 15. Oral Vaccine Delivery Consumed in Public
Figure 16. Global Oral Vaccine Delivery Market: Public (2018-2023) & (K Units)
Figure 17. Oral Vaccine Delivery Consumed in Private
Figure 18. Global Oral Vaccine Delivery Market: Private (2018-2023) & (K Units)
Figure 19. Global Oral Vaccine Delivery Sales Market Share by Application (2022)
Figure 20. Global Oral Vaccine Delivery Revenue Market Share by Application in 2022
Figure 21. Oral Vaccine Delivery Sales Market by Company in 2022 (K Units)
Figure 22. Global Oral Vaccine Delivery Sales Market Share by Company in 2022
Figure 23. Oral Vaccine Delivery Revenue Market by Company in 2022 ($ Million)
Figure 24. Global Oral Vaccine Delivery Revenue Market Share by Company in 2022
Figure 25. Global Oral Vaccine Delivery Sales Market Share by Geographic Region (2018-2023)
Figure 26. Global Oral Vaccine Delivery Revenue Market Share by Geographic Region in 2022
Figure 27. Americas Oral Vaccine Delivery Sales 2018-2023 (K Units)
Figure 28. Americas Oral Vaccine Delivery Revenue 2018-2023 ($ Millions)
Figure 29. APAC Oral Vaccine Delivery Sales 2018-2023 (K Units)
Figure 30. APAC Oral Vaccine Delivery Revenue 2018-2023 ($ Millions)
Figure 31. Europe Oral Vaccine Delivery Sales 2018-2023 (K Units)
Figure 32. Europe Oral Vaccine Delivery Revenue 2018-2023 ($ Millions)
Figure 33. Middle East & Africa Oral Vaccine Delivery Sales 2018-2023 (K Units)
Figure 34. Middle East & Africa Oral Vaccine Delivery Revenue 2018-2023 ($ Millions)
Figure 35. Americas Oral Vaccine Delivery Sales Market Share by Country in 2022
Figure 36. Americas Oral Vaccine Delivery Revenue Market Share by Country in 2022
Figure 37. Americas Oral Vaccine Delivery Sales Market Share by Type (2018-2023)
Figure 38. Americas Oral Vaccine Delivery Sales Market Share by Application (2018-2023)
Figure 39. United States Oral Vaccine Delivery Revenue Growth 2018-2023 ($ Millions)
Figure 40. Canada Oral Vaccine Delivery Revenue Growth 2018-2023 ($ Millions)
Figure 41. Mexico Oral Vaccine Delivery Revenue Growth 2018-2023 ($ Millions)
Figure 42. Brazil Oral Vaccine Delivery Revenue Growth 2018-2023 ($ Millions)
Figure 43. APAC Oral Vaccine Delivery Sales Market Share by Region in 2022
Figure 44. APAC Oral Vaccine Delivery Revenue Market Share by Regions in 2022
Figure 45. APAC Oral Vaccine Delivery Sales Market Share by Type (2018-2023)
Figure 46. APAC Oral Vaccine Delivery Sales Market Share by Application (2018-2023)
Figure 47. China Oral Vaccine Delivery Revenue Growth 2018-2023 ($ Millions)
Figure 48. Japan Oral Vaccine Delivery Revenue Growth 2018-2023 ($ Millions)
Figure 49. South Korea Oral Vaccine Delivery Revenue Growth 2018-2023 ($ Millions)
Figure 50. Southeast Asia Oral Vaccine Delivery Revenue Growth 2018-2023 ($ Millions)
Figure 51. India Oral Vaccine Delivery Revenue Growth 2018-2023 ($ Millions)
Figure 52. Australia Oral Vaccine Delivery Revenue Growth 2018-2023 ($ Millions)
Figure 53. China Taiwan Oral Vaccine Delivery Revenue Growth 2018-2023 ($ Millions)
Figure 54. Europe Oral Vaccine Delivery Sales Market Share by Country in 2022
Figure 55. Europe Oral Vaccine Delivery Revenue Market Share by Country in 2022
Figure 56. Europe Oral Vaccine Delivery Sales Market Share by Type (2018-2023)
Figure 57. Europe Oral Vaccine Delivery Sales Market Share by Application (2018-2023)
Figure 58. Germany Oral Vaccine Delivery Revenue Growth 2018-2023 ($ Millions)
Figure 59. France Oral Vaccine Delivery Revenue Growth 2018-2023 ($ Millions)
Figure 60. UK Oral Vaccine Delivery Revenue Growth 2018-2023 ($ Millions)
Figure 61. Italy Oral Vaccine Delivery Revenue Growth 2018-2023 ($ Millions)
Figure 62. Russia Oral Vaccine Delivery Revenue Growth 2018-2023 ($ Millions)
Figure 63. Middle East & Africa Oral Vaccine Delivery Sales Market Share by Country in 2022
Figure 64. Middle East & Africa Oral Vaccine Delivery Revenue Market Share by Country in 2022
Figure 65. Middle East & Africa Oral Vaccine Delivery Sales Market Share by Type (2018-2023)
Figure 66. Middle East & Africa Oral Vaccine Delivery Sales Market Share by Application (2018-2023)
Figure 67. Egypt Oral Vaccine Delivery Revenue Growth 2018-2023 ($ Millions)
Figure 68. South Africa Oral Vaccine Delivery Revenue Growth 2018-2023 ($ Millions)
Figure 69. Israel Oral Vaccine Delivery Revenue Growth 2018-2023 ($ Millions)
Figure 70. Turkey Oral Vaccine Delivery Revenue Growth 2018-2023 ($ Millions)
Figure 71. GCC Country Oral Vaccine Delivery Revenue Growth 2018-2023 ($ Millions)
Figure 72. Manufacturing Cost Structure Analysis of Oral Vaccine Delivery in 2022
Figure 73. Manufacturing Process Analysis of Oral Vaccine Delivery
Figure 74. Industry Chain Structure of Oral Vaccine Delivery
Figure 75. Channels of Distribution
Figure 76. Global Oral Vaccine Delivery Sales Market Forecast by Region (2024-2029)
Figure 77. Global Oral Vaccine Delivery Revenue Market Share Forecast by Region (2024-2029)
Figure 78. Global Oral Vaccine Delivery Sales Market Share Forecast by Type (2024-2029)
Figure 79. Global Oral Vaccine Delivery Revenue Market Share Forecast by Type (2024-2029)
Figure 80. Global Oral Vaccine Delivery Sales Market Share Forecast by Application (2024-2029)
Figure 81. Global Oral Vaccine Delivery Revenue Market Share Forecast by Application (2024-2029)


★調査レポート[世界の経口ワクチン投与市場予測 2023年-2029年] (コード：LP23DC01801)販売に関する免責事項を必ずご確認ください。
★調査レポート[世界の経口ワクチン投与市場予測 2023年-2029年]についてメールでお問い合わせ
◆関連市場調査レポート◆
  • 世界の経口新型コロナウイルス感染症ワクチン市場予測 2023年-2029年
  • 世界の経口投与ワクチン市場予測 2023年-2029年
  • 世界のmRNA新型コロナウイルスワクチン市場予測 2023年-2029年
  • 世界のワクチン製造装置市場予測 2023年-2029年
  • 世界の吸入用組換え新型コロナウイルスワクチン市場予測 2023年-2029年

    • ◆H&Iグローバルリサーチのお客様（例）◆